Table 1.
Demographic, laboratory and histopathological parameters in all patients n (%)
| Parameter | All patients (n = 46) |
| Age (yr) | 10.32 ± 3.46 |
| Male | 33 (71.7) |
| Duration of infection (yr) | 5.29 ± 3.97 |
| BMI | 18.20 ± 2.77 |
| Possible risk of infection | |
| Surgery | 14 (30.4) |
| Blood transfusion | 16 (34.8) |
| Tonsillectomy | 5 (10.9) |
| Circumcision | 33 (71.7) |
| Minor procedures1 | 30 (65.2) |
| Vertical transmission | 8 (17.4) |
| Family contact | 18 (39.1) |
| More than one possible risk | 43 (93.5) |
| Unknown risk factor | 3 (6.5) |
| Hemoglobin (g/dL) | 12.5 ± 1.1 |
| ANC (× 103/μL) | 3.13 ± 1.7 |
| Platelets (× 103/μL) | 280.7 ± 82.4 |
| Albumin (g/dL) | 4.1 ± 0.37 |
| Alanine transaminase (U/L) | 56.6 ± 55.03 |
| Aspartate transaminase (U/L) | 49.2 ± 31.65 |
| Gamma-glutamyl transpeptidase (U/L) | 32.1 ± 26.6 |
| Alkaline phosphatase (U/L) | 212.5 ± 96.1 |
| Prothrombin time (sec) | 12.9 ± 0.62 |
| Hepatomegaly (US) | 3 (15.9) |
| Splenomegaly (US) | 3 (15.9) |
| Viremia (IU/mL) | |
| Low (≤ 2 × 105 IU/mL) | 19 (41.3) |
| Moderate (> 2 × 105 - 2 × 106 IU/mL) | 25 (54.3) |
| High (> 2 × 106 IU/mL) | 2 (4.3) |
| Genotype: | |
| 4a | 30 (65.2) |
| 4b | 8 (17.4) |
| Not determined | 8 (17.4) |
| Fibrosis stage | |
| Absent | 13 (28.9) |
| Mild | 30 (66.7) |
| Moderate | 2 (4.4) |
| Activity grade | |
| Mild | 44 (97.8) |
| Moderate | 1 (2.2) |
1
Minor procedures were: Sutures, abscess drainage, ICU hospitalization, endoscopy, ear piercing, tattooing, prolonged hospitalization and dental care. US: Ultrasound; BMI: Body mass index.